

Can't find Bacitracin? Learn about effective alternatives including Polysporin, Neosporin, Mupirocin, and other options for wound and eye care.
If your pharmacy is out of Bacitracin — whether it's the OTC topical ointment or the prescription ophthalmic form — you don't have to wait around for it to come back in stock. There are several effective alternatives that can help you treat minor wounds or eye infections.
In this article, we'll explain what Bacitracin is, how it works, and walk you through the best alternatives so you can talk to your doctor or pharmacist about switching.
Bacitracin is a polypeptide antibiotic that's been used in the United States since the late 1940s. It's one of the most common topical antibiotics found in first aid kits across the country.
Bacitracin comes in two main forms:
For a complete overview, read our guide on what Bacitracin is and how it's used.
Bacitracin kills bacteria by interfering with cell wall synthesis. Specifically, it blocks the dephosphorylation of a lipid carrier molecule called C55-isoprenyl pyrophosphate. This molecule is essential for transporting building blocks across the bacterial membrane to construct the cell wall. Without it, bacteria can't build or maintain their cell walls and they die.
This mechanism makes Bacitracin effective against many gram-positive bacteria, including Staphylococcus and Streptococcus species — the most common culprits in skin infections. For a deeper dive, check out how Bacitracin works.
If you need Bacitracin for cuts, scrapes, or burns, these alternatives are widely available:
Polysporin is a double antibiotic ointment that actually contains Bacitracin along with Polymyxin B. The addition of Polymyxin B provides broader antibacterial coverage, including some gram-negative bacteria that Bacitracin alone doesn't cover.
Neosporin is the well-known triple antibiotic ointment. It covers the broadest range of bacteria among OTC antibiotic ointments because it combines three different antibiotics.
Mupirocin is a prescription-only topical antibiotic that works differently from Bacitracin. It inhibits bacterial protein synthesis rather than cell wall synthesis.
This might surprise you, but studies have shown that plain petroleum jelly is just as effective as antibiotic ointments at preventing infection in clean minor wounds. Many dermatologists now recommend it as a first-line wound care option.
If you need an alternative for the prescription eye ointment — which is currently in shortage — your doctor has several options:
Only your eye doctor or prescriber can determine which alternative is right for your specific infection. Don't try to substitute one eye medication for another on your own.
Choosing the right alternative depends on a few factors:
When in doubt, talk to your pharmacist — they can help you choose the best OTC option, or contact your doctor if you need a prescription alternative.
If you'd prefer to stick with Bacitracin, it may still be available at some pharmacies. Use Medfinder to check stock near you, or read our guide on how to find Bacitracin in stock. You can also learn about the current shortage situation in our Bacitracin shortage update for 2026.
Not being able to find Bacitracin is frustrating, but it doesn't mean you're out of options. For minor wound care, Polysporin, Neosporin, Mupirocin, and even plain petroleum jelly are all solid alternatives. For eye infections, your doctor can prescribe other ophthalmic antibiotics that work just as well.
The most important thing is not to skip treatment because one product is unavailable. Talk to your doctor or pharmacist about the best alternative for your situation, and use Medfinder to help you find what you need.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.